Diagnosing rare genetic diseases is a lengthy and complex process, often taking an average of seven years, which delays appropriate treatment and management, especially for newborns and children. Existing diagnostic methods may lack the comprehensiveness needed to identify the underlying genetic causes of these conditions, leading to prolonged uncertainty for patients and their families.

Vgenomics offers comprehensive genomic sequencing and analysis services designed to accelerate the diagnosis and therapeutic development for rare and undiagnosed genetic diseases. The company utilizes whole-genome sequencing (WGS), whole-exome sequencing (WES), and RNA sequencing (RNA-Seq) to provide a complete genetic profile, aiding clinicians in identifying causative variants. Vgenomics focuses on delivering actionable insights through detailed clinical reports, variant classification, and data reanalysis for newly identified variants, ensuring up-to-date information for personalized care. By leveraging advanced genomic technologies and bioinformatics, Vgenomics aims to reduce the time to diagnosis and facilitate the development of targeted therapies for rare diseases.

Whole Genome Sequencing (WGS) providing a comprehensive analysis of the entire genome

Whole Exome Sequencing (WES) targeting protein-coding regions for cost-effective identification of disease-causing variants

RNA Sequencing (RNA-Seq) offering insights into gene expression patterns and biomarker discovery

Detailed clinical reports with South Asia data references

Variant classification, including Variants of Uncertain Significance (VUS)

Reanalysis of patient data for newly identified variants and expanded phenotypes

Family data reuse to investigate inherited conditions

Data mining and machine learning techniques to uncover patterns and genetic variant associations

Epigenomics and Metagenomics analysis

Vgenomics serves neonatologists, pediatricians, gynecologists, and clinical researchers focused on diagnosing and treating rare genetic diseases, as well as patients and their families seeking answers and personalized care options.